No impact of soluble epoxide hydrolase rs4149243, rs2234914 and rs751142 genetic variants on the development of type II diabetes and its hypertensive complication among Jordanian patients

2021 ◽  
Author(s):  
Maysoon Khamees ◽  
Yazun Jarrar ◽  
Tariq Al‐Qirim ◽  
Ismail Sami Mahmoud ◽  
Ma’mon M. Hatmal ◽  
...  
Keyword(s):  
Genetic Variants ◽  
Type Ii Diabetes ◽  
Epoxide Hydrolase ◽  
Soluble Epoxide Hydrolase ◽  
Type Ii

scholarly journals Design and synthesis of fused soluble epoxide hydrolase/peroxisome proliferator-activated receptor modulators

MedChemComm ◽  
2016 ◽  
Vol 7 (6) ◽  
pp. 1209-1216 ◽  
Author(s):  
R. Blöcher ◽  
C. Lamers ◽  
S. K. Wittmann ◽  
O. Diehl ◽  
T. Hanke ◽  
...  
Keyword(s):  
Type Ii Diabetes ◽  
Epoxide Hydrolase ◽  
Complex Disease ◽  
Soluble Epoxide Hydrolase ◽  
Peroxisome Proliferator ◽  
Type Ii ◽  
Peroxisome Proliferator Activated Receptor ◽  
Design And Synthesis ◽  
Disease Cluster ◽  
Receptor Modulators

Metabolic syndrome (MetS) is a widespread, complex disease cluster which consists of hypertension, atherosclerosis, dyslipidaemia and type II diabetes.

Sign in / Sign up

Export Citation Format

Share Document